Factor | ORa(95% CI) | RIa | WTAa(95%CI) ($AUD) | |||
---|---|---|---|---|---|---|
Pain Efficacy b (decreasing) | 1.00 (0.97-1.04) | N/Aa | 0.08 (0.04-0.11) | |||
Mode of action c (Slow OA a ) | 1.17 (1.09-1.25)* | 5 | 13.83 (13.73-13.93) | |||
Dose frequency b (once/day) | 1.02 (0.96-1.08) | 0.58 (0.42-0.75) | ||||
Treatment Schedule c (daily) | 0.90 (0.89-0.9)* | 4 | 4.11 (3.92-4.29) | |||
Cost b (increasing) | 0.97 (0.97-0.98)* | 2 | N/Aa | |||
Prescription b (Yes) | 1.03 (0.97-1.09) | N/A a | 1.00 (0.83-1.16) | |||
Side effects | ||||||
Drowsy/constipatedc | 1.55 (1.48-1.62)* | 6 | 18.06 (17.90-18.23) | |||
Heartburn/reflux, stomach ulcersc | 0.76 (0.75-0.78)* | 3 | 10.67 (10.55-10.78) | |||
High blood pressure, heart/kidney/liver problemsc | 0.09 (0.08-0.11)* | 1 | 90.50 (89.38-91.62) | |||
Constant b (α) | N/Aa | N/Aa | ||||
Model Fit Statistics | Log Likelihood | −1271 | McFaddens ρ2 adjusted | 0.37 | AICa | 0.869 |